Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade.
Cloherty APM, Rader AG, Patel KS, Pérez-Vargas J, Thompson CAH, Ennis S, Niikura M, Wildenberg ME, Muncan V, Schreurs RRCE, Jean F, Ribeiro CMS. Cloherty APM, et al. Among authors: wildenberg me. Emerg Microbes Infect. 2023 Dec;12(1):2195020. doi: 10.1080/22221751.2023.2195020. Emerg Microbes Infect. 2023. PMID: 36951188 Free PMC article.
High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn's Disease in a Randomized Placebo-Controlled Trial.
de Bruyn JR, Bossuyt P, Ferrante M, West RL, Dijkstra G, Witteman BJ, Wildenberg M, Hoentjen F, Franchimont D, Clasquin E, van der Bilt JD, Tollens T, Bemelman WA, D'Hoore A, Duijvestein M, D'Haens GR; Dutch-Belgian The Effect of Vitamin D3 to Prevent Postoperative Relapse of Crohn’s Disease: A Placebo-controlled Randomized Trial Study Group. de Bruyn JR, et al. Clin Gastroenterol Hepatol. 2021 Aug;19(8):1573-1582.e5. doi: 10.1016/j.cgh.2020.05.037. Epub 2020 May 24. Clin Gastroenterol Hepatol. 2021. PMID: 32461138 Free article. Clinical Trial.
Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis.
Duijvestein M, Wildenberg ME, Welling MM, Hennink S, Molendijk I, van Zuylen VL, Bosse T, Vos AC, de Jonge-Muller ES, Roelofs H, van der Weerd L, Verspaget HW, Fibbe WE, te Velde AA, van den Brink GR, Hommes DW. Duijvestein M, et al. Among authors: wildenberg me. Stem Cells. 2011 Oct;29(10):1549-58. doi: 10.1002/stem.698. Stem Cells. 2011. PMID: 21898680
Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses.
Sutmuller RP, van Duivenvoorde LM, van Elsas A, Schumacher TN, Wildenberg ME, Allison JP, Toes RE, Offringa R, Melief CJ. Sutmuller RP, et al. Among authors: wildenberg me. J Exp Med. 2001 Sep 17;194(6):823-32. doi: 10.1084/jem.194.6.823. J Exp Med. 2001. PMID: 11560997 Free PMC article.
Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression.
Brkic Z, Maria NI, van Helden-Meeuwsen CG, van de Merwe JP, van Daele PL, Dalm VA, Wildenberg ME, Beumer W, Drexhage HA, Versnel MA. Brkic Z, et al. Among authors: wildenberg me. Ann Rheum Dis. 2013 May;72(5):728-35. doi: 10.1136/annrheumdis-2012-201381. Epub 2012 Jun 26. Ann Rheum Dis. 2013. PMID: 22736090 Free PMC article.
Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency.
Roos A, Garred P, Wildenberg ME, Lynch NJ, Munoz JR, Zuiverloon TC, Bouwman LH, Schlagwein N, Fallaux van den Houten FC, Faber-Krol MC, Madsen HO, Schwaeble WJ, Matsushita M, Fujita T, Daha MR. Roos A, et al. Among authors: wildenberg me. Eur J Immunol. 2004 Sep;34(9):2589-98. doi: 10.1002/eji.200324401. Eur J Immunol. 2004. PMID: 15307191 Free article.
91 results